Facundo Garreton

By Javier Hasse via El Planteo In a recent announcement that has stirred interest in the dietary supplement industry, Terraflos Group has exclusively confirmed its collaboration with Colombian firm Nutripharma. While Terraflos has made a name for itself in harnessing artificial intelligence for...

Blueberries Medical Corp. (OTCQB: BBRRF) (CSE:BBM) (FRA:1OA) released its financial results for the quarter ended on June 30, 2022, revealing total revenue of CA$39,826, an increase of CA$25,041 (or 169%) compared to Q2 2021. Q2 2022 Financial Highlights The gross profit, excluding the direct...

Blueberries Medical Corp. (OTCQB: BBRRF) (CSE:BBM) (FRA:1OA) has achieved several CBD and non-psychoactive derivatives shipments to customers in Argentina, and up to date has exported a total of more than 60 kg to 6 different buyers. Quality validation processes with larger pharmaceutical and...

On Monday, Blueberries Medical Corp. (CSE:BBM) (OTC: BBRRF) (FRA:1OA), the Canadian parent of Blueberries S.A.S., a Latin American licensed producer of naturally grown premium quality cannabis operating from central Colombia, reported its financial results for the quarter ended on March 31, 2022....

Blueberries Medical Corp. (OTCQB: BBRRF) (CSE: BBM) (FRA: 1OA) the Canadian parent of Blueberries S.A.S., reported its financial results for the year ended December 31, 2021. 2021 Financial Highlights Net loss was CA$5.15 million ($4.02 million) compared to net loss of CA$4.94 million in 2020...

Latin American medicinal cannabis producer Blueberries Medical Corp. (CSE: BBM) (OTCQB: BBRRF) collected CA$1 million ($788,495) via a non-brokered private placement sale at CA$0.065 per share. Buenos Aires, Argentina-based private equity firm FLA Ventures Ltd. led the offering and is now...